TrialCancer chemotherapy and pharmacology2021

A phase 1 randomized study compare the pharmacokinetics, safety and immunogenicity of HLX04 to reference bevacizumab sourced from the United States, the European Union, and China in healthy Chinese male volunteers.

Xiaoxue Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.